세계의 수의용 정맥 주입액 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 적응증별, 동물 유형별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Veterinary Intravenous Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Animal type, By End Use, By Region & Competition, 2020-2030F
세계의 수의용 정맥 주입액 시장은 2024년에는 13억 5,000만 달러로 평가되었고, 예측 기간 중의 CAGR은 6.57%로 성장할 전망입니다.
이 성장은 수의학 분야의 기술 발전과 인간 의료 분야의 트렌드를 반영한 것으로, IV 용액이 치료 프로토콜의 핵심 요소로 자리 잡은 점을 반영합니다. 수의용 정맥 주입액은 다양한 동물 종에서 수분 공급, 약물 투여, 중환자 치료에 필수적입니다. 전 세계 반려동물 소유율 증가, 동물 돌봄에 대한 기대치 상승, 보험 가입 반려동물 수의 증가가 이 수요 급증의 주요 요인입니다. 이 솔루션은 일상적인 상황과 응급 상황 모두에서 사용되며, 수의학 환경에서 회복과 치료 효과를 지원합니다. 인간과 동물 간의 유대감이 강화되고 반려동물 관리가 더욱 정교해짐에 따라 신뢰성 있고 효과적인 정맥 내 치료에 대한 수요가 계속 증가하며, 이는 전 세계 시장 확장을 이끌고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모(2024년) |
13억 5,000만 달러 |
| 시장 규모(2030년) |
19억 6,000만 달러 |
| CAGR(2025-2030년) |
6.57% |
| 급성장 부문 |
반려동물 |
| 최대 시장 |
북미 |
주요 시장 성장 촉진요인
반려동물 소유율 증가와 인간화 추세가 세계의 수의용 정맥 주입액 시장을 주도
주요 시장 과제
제한된 연구 및 제형 다양성이 시장 확장 장애물로 작용
주요 시장 동향
기술 진보
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 수의용 정맥 주입액 시장 전망
- 시장 규모와 예측
- 시장 점유율 및 예측
- 제품별(등장성 결정질 용액, 합성콜로이드, 혈액제제, 포도당액, 정맥 영양제)
- 적응증별(당뇨병성 케톤산증, 췌장염, 탄저병, 만성 신장병, 기타)
- 동물 유형별(반려동물, 생산 동물)
- 용도별(동물병원, 연구기관, 기타)
- 지역별
- 기업별(시장 상위 5개사 점유율)
- 시장 맵
- 제품별
- 적응증별
- 동물 유형별
- 최종 용도별
- 지역별
제6장 북미의 수의용 정맥 주입액 시장 전망
제7장 유럽의 수의용 정맥 주입액 시장 전망
제8장 아시아태평양의 수의용 정맥 주입액 시장 전망
제9장 남미의 수의용 정맥 주입액 시장 전망
제10장 중동 및 아프리카의 수의용 정맥 주입액 시장 전망
제11장 시장 역학
제12장 시장 동향과 발전
제13장 경쟁 구도
- Merck & Co., Inc.
- Dechra Veterinary Products
- Sypharma
- Animalcare
- B. Braun SE
- Woods Consulting, LLC
- Baxter International
- Fresenius Kabi
제14장 전략적 제안
제15장 기업 소개와 면책사항
HBR
The Global Veterinary Intravenous (IV) Solutions Market was valued at USD 1.35 billion in 2024 and is projected to expand significantly, reaching new heights by 2030 with a CAGR of 6.57% during the forecast period. This growth reflects advancements in veterinary medicine, mirroring trends in human healthcare, where IV solutions are integral to treatment protocols. Veterinary IV solutions are crucial for hydration, medication delivery, and critical care across a variety of animal species. Increasing global pet ownership, heightened expectations for animal care, and the growing number of insured pets-such as the 6.25 million pets reported insured in North America in 2024-are major contributors to this surge in demand. These solutions are used in both routine and emergency situations, supporting recovery and treatment efficacy in veterinary settings. As the human-animal bond deepens and pet care becomes more sophisticated, the need for reliable, effective IV therapies continues to grow, driving market expansion worldwide.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.35 Billion |
| Market Size 2030 | USD 1.96 Billion |
| CAGR 2025-2030 | 6.57% |
| Fastest Growing Segment | Companion Animal |
| Largest Market | North America |
Key Market Drivers
Rising Pet Ownership and Humanization is Driving the Global Veterinary Intravenous (IV) Solutions Market
The rapid increase in global pet ownership and the growing trend of treating pets as family members are significantly boosting demand for veterinary healthcare services, including IV solutions. In the U.S., approximately 67% of households own a pet, a trend echoed in many other regions. This humanization of pets has transformed the way owners approach healthcare, prompting greater interest in advanced medical treatments similar to those used for humans. Veterinary IV solutions, vital for administering fluids, medications, and nutrients during critical care, are increasingly in demand as pet owners seek comprehensive and high-quality medical support. The surge in pet insurance coverage also supports this growth by making advanced veterinary treatments more financially accessible, encouraging more pet owners to opt for intensive interventions that include IV therapy.
Key Market Challenges
Limited Research and Formulation Variety Poses a Significant Obstacle To Market Expansion
A significant challenge facing the veterinary IV solutions market is the limited research and formulation diversity tailored to various animal species. Unlike human IV solutions, which benefit from extensive R&D and specificity, veterinary formulations often lack the same level of customization. This is particularly problematic for exotic and less common species that have unique physiological needs not addressed by standard formulations. The limited number of species-specific products restricts veterinarians' ability to deliver optimal care, which can impact treatment outcomes. This gap in product variety hinders market expansion and highlights the need for increased investment in research to develop a broader range of targeted IV solutions across diverse animal categories.
Key Market Trends
Technological Advancements
The integration of precision medicine and digital health technologies is reshaping the veterinary IV solutions market. Diagnostic innovations, such as genetic testing, allow for the formulation of personalized IV therapies, improving treatment effectiveness and patient outcomes. Telemedicine platforms and remote monitoring tools are also revolutionizing care delivery, enabling veterinarians to track patient vitals and modify IV regimens in real time without in-person visits. Moreover, smart infusion pumps and automated delivery systems enhance accuracy and safety by precisely controlling fluid and medication administration. These systems can adapt dosages dynamically based on live data. The adoption of digital health records and analytics further supports data-driven treatment decisions, improving care outcomes and contributing to the evolution of more targeted, efficient, and intelligent veterinary healthcare protocols.
Key Market Players
- Merck & Co., Inc.
- Dechra Veterinary Products
- Sypharma Pty Ltd.
- Animalcare group plc
- Braun SE
- Woods Consulting, LLC
- Baxter International
- Fresenius Kabi
Report Scope:
In this report, the Global Veterinary Intravenous (IV) Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Veterinary Intravenous (IV) Solutions Market, By Product:
- Isotonic crystalloids
- Synthetic colloids
- Blood products
- Dextrose solutions
- Parenteral nutrition
Veterinary Intravenous (IV) Solutions Market, By Indication:
- Diabetic Ketoacidosis
- Pancreatitis
- Anthrax
- Chronic Kidney Disease
- Others
Veterinary Intravenous (IV) Solutions Market, By Animal Type:
- Companion Animals
- Production Animals
Veterinary Intravenous (IV) Solutions Market, By End Use:
- Veterinary Hospitals
- Research Institutes
- Others
Veterinary Intravenous (IV) Solutions Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Intravenous (IV) Solutions Market.
Available Customizations:
Global Veterinary Intravenous (IV) Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validations
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Veterinary Intravenous (IV) Solutions Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition)
- 5.2.2. By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others)
- 5.2.3. By Animal type (Companion Animals, Production Animals)
- 5.2.4. By End Use (Veterinary Hospitals, Research Institutes, Others)
- 5.2.5. By Region
- 5.2.6. By Company (Shares of Top 5 Market Players)
- 5.3. Market Map
- 5.3.1. By Product
- 5.3.2. By Indication
- 5.3.3. By Animal type
- 5.3.4. By End Use
- 5.3.5. By Region
6. North America Veterinary Intravenous (IV) Solutions Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Indication
- 6.2.3. By Animal type
- 6.2.4. By End Use
- 6.2.5. By Country
- 6.2.5.1. United States Veterinary Intravenous (IV) Solutions Market Outlook
- 6.2.5.1.1. Market Size & Forecast
- 6.2.5.1.1.1. By Value
- 6.2.5.1.2. Market Share & Forecast
- 6.2.5.1.2.1. By Product
- 6.2.5.1.2.2. By Indication
- 6.2.5.1.2.3. By Animal type
- 6.2.5.1.2.4. By End Use
- 6.2.5.2. Canada Veterinary Intravenous (IV) Solutions Market Outlook
- 6.2.5.2.1. Market Size & Forecast
- 6.2.5.2.1.1. By Value
- 6.2.5.2.2. Market Share & Forecast
- 6.2.5.2.2.1. By Product
- 6.2.5.2.2.2. By Indication
- 6.2.5.2.2.3. By Animal type
- 6.2.5.2.2.4. By End Use
- 6.2.5.3. Mexico Veterinary Intravenous (IV) Solutions Market Outlook
- 6.2.5.3.1. Market Size & Forecast
- 6.2.5.3.1.1. By Value
- 6.2.5.3.2. Market Share & Forecast
- 6.2.5.3.2.1. By Product
- 6.2.5.3.2.2. By Indication
- 6.2.5.3.2.3. By Animal type
- 6.2.5.3.2.4. By End Use
7. Europe Veterinary Intravenous (IV) Solutions Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Indication
- 7.2.3. By Animal type
- 7.2.4. By End Use
- 7.2.5. By Country
- 7.2.5.1. France Veterinary Intravenous (IV) Solutions Market Outlook
- 7.2.5.1.1. Market Size & Forecast
- 7.2.5.1.1.1. By Value
- 7.2.5.1.2. Market Share & Forecast
- 7.2.5.1.2.1. By Product
- 7.2.5.1.2.2. By Indication
- 7.2.5.1.2.3. By Animal type
- 7.2.5.1.2.4. By End Use
- 7.2.5.2. Germany Veterinary Intravenous (IV) Solutions Market Outlook
- 7.2.5.2.1. Market Size & Forecast
- 7.2.5.2.1.1. By Value
- 7.2.5.2.2. Market Share & Forecast
- 7.2.5.2.2.1. By Product
- 7.2.5.2.2.2. By Indication
- 7.2.5.2.2.3. By Animal type
- 7.2.5.2.2.4. By End Use
- 7.2.5.3. United Kingdom Veterinary Intravenous (IV) Solutions Market Outlook
- 7.2.5.3.1. Market Size & Forecast
- 7.2.5.3.1.1. By Value
- 7.2.5.3.2. Market Share & Forecast
- 7.2.5.3.2.1. By Product
- 7.2.5.3.2.2. By Indication
- 7.2.5.3.2.3. By Animal type
- 7.2.5.3.2.4. By End Use
- 7.2.5.4. Italy Veterinary Intravenous (IV) Solutions Market Outlook
- 7.2.5.4.1. Market Size & Forecast
- 7.2.5.4.1.1. By Value
- 7.2.5.4.2. Market Share & Forecast
- 7.2.5.4.2.1. By Product
- 7.2.5.4.2.2. By Indication
- 7.2.5.4.2.3. By Animal type
- 7.2.5.4.2.4. By End Use
- 7.2.5.5. Spain Veterinary Intravenous (IV) Solutions Market Outlook
- 7.2.5.5.1. Market Size & Forecast
- 7.2.5.5.1.1. By Value
- 7.2.5.5.2. Market Share & Forecast
- 7.2.5.5.2.1. By Product
- 7.2.5.5.2.2. By Indication
- 7.2.5.5.2.3. By Animal type
- 7.2.5.5.2.4. By End Use
8. Asia Pacific Veterinary Intravenous (IV) Solutions Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Indication
- 8.2.3. By Animal type
- 8.2.4. By End Use
- 8.2.5. By Country
- 8.2.5.1. China Veterinary Intravenous (IV) Solutions Market Outlook
- 8.2.5.1.1. Market Size & Forecast
- 8.2.5.1.1.1. By Value
- 8.2.5.1.2. Market Share & Forecast
- 8.2.5.1.2.1. By Product
- 8.2.5.1.2.2. By Indication
- 8.2.5.1.2.3. By Animal type
- 8.2.5.1.2.4. By End Use
- 8.2.5.2. India Veterinary Intravenous (IV) Solutions Market Outlook
- 8.2.5.2.1. Market Size & Forecast
- 8.2.5.2.1.1. By Value
- 8.2.5.2.2. Market Share & Forecast
- 8.2.5.2.2.1. By Product
- 8.2.5.2.2.2. By Indication
- 8.2.5.2.2.3. By Animal type
- 8.2.5.2.2.4. By End Use
- 8.2.5.3. South Korea Veterinary Intravenous (IV) Solutions Market Outlook
- 8.2.5.3.1. Market Size & Forecast
- 8.2.5.3.1.1. By Value
- 8.2.5.3.2. Market Share & Forecast
- 8.2.5.3.2.1. By Product
- 8.2.5.3.2.2. By Indication
- 8.2.5.3.2.3. By Animal type
- 8.2.5.3.2.4. By End Use
- 8.2.5.4. Japan Veterinary Intravenous (IV) Solutions Market Outlook
- 8.2.5.4.1. Market Size & Forecast
- 8.2.5.4.1.1. By Value
- 8.2.5.4.2. Market Share & Forecast
- 8.2.5.4.2.1. By Product
- 8.2.5.4.2.2. By Indication
- 8.2.5.4.2.3. By Animal type
- 8.2.5.4.2.4. By End Use
- 8.2.5.5. Australia Veterinary Intravenous (IV) Solutions Market Outlook
- 8.2.5.5.1. Market Size & Forecast
- 8.2.5.5.1.1. By Value
- 8.2.5.5.2. Market Share & Forecast
- 8.2.5.5.2.1. By Product
- 8.2.5.5.2.2. By Indication
- 8.2.5.5.2.3. By Animal type
- 8.2.5.5.2.4. By End Use
9. South America Veterinary Intravenous (IV) Solutions Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Indication
- 9.2.3. By Animal type
- 9.2.4. By End Use
- 9.2.5. By Country
- 9.2.5.1. Brazil Veterinary Intravenous (IV) Solutions Market Outlook
- 9.2.5.1.1. Market Size & Forecast
- 9.2.5.1.1.1. By Value
- 9.2.5.1.2. Market Share & Forecast
- 9.2.5.1.2.1. By Product
- 9.2.5.1.2.2. By Indication
- 9.2.5.1.2.3. By Animal type
- 9.2.5.1.2.4. By End Use
- 9.2.5.2. Argentina Veterinary Intravenous (IV) Solutions Market Outlook
- 9.2.5.2.1. Market Size & Forecast
- 9.2.5.2.1.1. By Value
- 9.2.5.2.2. Market Share & Forecast
- 9.2.5.2.2.1. By Product
- 9.2.5.2.2.2. By Indication
- 9.2.5.2.2.3. By Animal type
- 9.2.5.2.2.4. By End Use
- 9.2.5.3. Colombia Veterinary Intravenous (IV) Solutions Market Outlook
- 9.2.5.3.1. Market Size & Forecast
- 9.2.5.3.1.1. By Value
- 9.2.5.3.2. Market Share & Forecast
- 9.2.5.3.2.1. By Product
- 9.2.5.3.2.2. By Indication
- 9.2.5.3.2.3. By Animal type
- 9.2.5.3.2.4. By End Use
10. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Indication
- 10.2.3. By Animal type
- 10.2.4. By End Use
- 10.2.5. By Country
- 10.2.5.1. South Africa Veterinary Intravenous (IV) Solutions Market Outlook
- 10.2.5.1.1. Market Size & Forecast
- 10.2.5.1.1.1. By Value
- 10.2.5.1.2. Market Share & Forecast
- 10.2.5.1.2.1. By Product
- 10.2.5.1.2.2. By Indication
- 10.2.5.1.2.3. By Animal type
- 10.2.5.1.2.4. By End Use
- 10.2.5.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Outlook
- 10.2.5.2.1. Market Size & Forecast
- 10.2.5.2.1.1. By Value
- 10.2.5.2.2. Market Share & Forecast
- 10.2.5.2.2.1. By Product
- 10.2.5.2.2.2. By Indication
- 10.2.5.2.2.3. By Animal type
- 10.2.5.2.2.4. By End Use
- 10.2.5.3. UAE Veterinary Intravenous (IV) Solutions Market Outlook
- 10.2.5.3.1. Market Size & Forecast
- 10.2.5.3.1.1. By Value
- 10.2.5.3.2. Market Share & Forecast
- 10.2.5.3.2.1. By Product
- 10.2.5.3.2.2. By Indication
- 10.2.5.3.2.3. By Animal type
- 10.2.5.3.2.4. By End Use
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Development
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
13. Competitive Landscape
- 13.1. Merck & Co., Inc.
- 13.1.1. Business Overview
- 13.1.2. Company Snapshot
- 13.1.3. Products & Service
- 13.1.4. Financials (As Reported)
- 13.1.5. Recent Developments
- 13.1.6. Key Personnel Details
- 13.1.7. SWOT Analysis
- 13.2. Dechra Veterinary Products
- 13.3. Sypharma
- 13.4. Animalcare
- 13.5. B. Braun SE
- 13.6. Woods Consulting, LLC
- 13.7. Baxter International
- 13.8. Fresenius Kabi
14. Strategic Recommendations
15. About us & Disclaimer
